Literature DB >> 2493376

Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.

T Sumer1, A Abumelha, I al-Mulhim, M al-Fadil.   

Abstract

Thirty-three children with leukemia who had neutropenia and fever were randomized to receive cefataxim and amikacin, versus the same antibiotics plus intravenous gammaglobulin (i.v. IgG). Duration of neutropenia, hospitalization and the interruption of chemotherapy were not different in the two groups; however, duration of fever was significantly shorter in the i.v. IgG group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493376     DOI: 10.1007/bf00595896

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Which is the factual basis, in theory and clinical practice, for the use of intravenous gammaglobulin in the treatment of severe bacterial infections?

Authors: 
Journal:  Vox Sang       Date:  1979       Impact factor: 2.144

Review 2.  Clinical use of immunoglobulins.

Authors:  D B McClelland; P L Yap
Journal:  Clin Haematol       Date:  1984-02

3.  Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.

Authors:  A Montanaro; B Pirofsky
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

4.  Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.

Authors:  R U Sorensen; S H Polmar
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

5.  Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indications.

Authors:  J B Bussel; C Cunningham-Rundles
Journal:  Cancer Invest       Date:  1985       Impact factor: 2.176

6.  In-vivo phagocytosis: enhancement of bacterial clearance by native and enzyme-treated immunoglobulins.

Authors:  W Ax; E J Kanzy; F R Seiler
Journal:  Immunobiology       Date:  1981       Impact factor: 3.144

7.  [Clinical studies of SM-4300 in children].

Authors:  I Nagamatsu; Y Sato; A Miyanoshita; K Abe
Journal:  Jpn J Antibiot       Date:  1985-09

8.  [Laboratory and clinical studies on SM-4300 in the pediatric field].

Authors:  T Takashima; K Tabuki; T Nishimura; M Takagi
Journal:  Jpn J Antibiot       Date:  1985-09

9.  Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.

Authors:  C Cunningham-Rundles; F P Siegal; E M Smithwick; A Lion-Boulé; S Cunningham-Rundles; J O'Malley; S Barandun; R A Good
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

10.  [The use of SM-4300 against severe infections complicated with hematological diseases].

Authors:  S Ikeda; M Ichimaru
Journal:  Jpn J Antibiot       Date:  1985-09
View more
  2 in total

1.  Prevalence and Safety of Intravenous Immunoglobulin Administration During Maintenance Chemotherapy in Children with Acute Lymphoblastic Leukemia in First Complete Remission: A Health Maintenance Organization Perspective.

Authors:  Patrick Van Winkle; Raoul Burchette; Raymond Kim; Rukmani Raghunathan; Naveen Qureshi
Journal:  Perm J       Date:  2018

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.